Literature DB >> 9203677

Interleukin-8 and chemotactic activity of middle ear effusions.

M Storgaard1, K Larsen, S Blegvad, H Nødgaard, T Ovesen, P L Andersen, N Obel.   

Abstract

The importance of interleukin (IL)-8 in the chemotactic activity of middle ear effusions (MEEs) was evaluated. There was a significantly higher IL-8 concentration in MEEs of children with acute otitis media (AOM) (n = 17; 136 ng/mL) than in children with otitis media with effusion (OME) (n = 28; 65 ng/mL). The IL-8 concentration in MEEs with bacteria (149 ng/mL) was significantly higher than in MEEs without bacteria (66 ng/mL). MEEs from children with AOM and OME had equally higher chemotactic activity than the diluent alone (23.3% and 24.8% vs. 9.2%). The chemotactic activity was not altered by the presence of bacteria nor did it correlate with IL-8 concentration. Fractionation of MEEs by gel chromatography demonstrated that the main chemotactic activity could clearly be separated from the IL-8 activity, thus excluding IL-8 as a main chemotactic component in MEEs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203677     DOI: 10.1093/infdis/175.2.474

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication.

Authors:  E Leibovitz; R Dagan; J H Laver; L Piglansky; S Raiz; M R Abboud; D M Fliss; A Leiberman; A Barzilai
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

Review 2.  Adenoidectomy and tympanostomy tubes in the management of otitis media.

Authors:  Petri S Mattila
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

3.  Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae.

Authors:  D L Clemans; R J Bauer; J A Hanson; M V Hobbs; J W St Geme; C F Marrs; J R Gilsdorf
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics.

Authors:  A Barzilai; E Leibovitz; J H Laver; L Piglansky; S Raiz; M R Abboud; D M Fliss; A Leiberman; R Dagan
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

5.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants.

Authors:  H H Tong; Y Chen; M James; J Van Deusen; D B Welling; T F DeMaria
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 6.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

7.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.

Authors:  H H Tong; J P Long; P A Shannon; T F DeMaria
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Lower nasopharyngeal epithelial cell repair and diminished innate inflammation responses contribute to the onset of acute otitis media in otitis-prone children.

Authors:  David Verhoeven; Monica Nesselbush; Michael E Pichichero
Journal:  Med Microbiol Immunol       Date:  2013-04-11       Impact factor: 3.402

Review 9.  Mouse models as a tool to unravel the genetic basis for human otitis media.

Authors:  Qing Yin Zheng; Rachel Hardisty-Hughes; Steve D M Brown
Journal:  Brain Res       Date:  2006-05-26       Impact factor: 3.252

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.